Wealth Enhancement Advisory Services’s Haemonetics HAE Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$883K	Buy	11,589 +1,079	+10%	+$69.3K	﹤0.01%	2164
2026 Q1	$597K	Buy	10,510 +184	+2%	+$12K	﹤0.01%	2177
2025 Q4	$855K	Buy	10,326 +4,370	+73%	+$294K	﹤0.01%	2061
2025 Q3	$293K	Buy	+5,956	New	+$369K	﹤0.01%	2814

Other funds holding HAE

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wealth Enhancement Advisory Services's HAE Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Haemonetics (HAE) stake by 10% in Q2 2026, buying an estimated $69.3K and bringing the position to 11,589 shares worth $883K. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

Wealth Enhancement Advisory Services first reported a position in HAE in Q3 2025 and has held it in 4 quarters since. 31 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Wealth Enhancement Advisory Services held 11,589 shares of Haemonetics worth $883K as of Q2 2026.
Wealth Enhancement Advisory Services bought 1,079 Haemonetics shares in Q2 2026, an estimated $69.3K.
Haemonetics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2164 holding.
Wealth Enhancement Advisory Services first reported a position in Haemonetics in Q3 2025 and has held it in 4 quarters since.
31 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.